Search research articles
Contact Us
Filters
Showing results (481-490 of 556) with videos related to
Page
of 56
Sort By:
World Journal of Gastroenterology
|
August 12, 2014
Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease
Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 8, 2021
Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study
Hirokazu Takahashi, Takashi Nakahara, Tomomi Kogiso, et al.
Journal of Gastroenterology
|
November 27, 2013
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
Takashi Nakahara, Hideyuki Hyogo, Masato Yoneda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 7, 2017
Prevalence of pruritus in patients with chronic liver disease: A multicenter study
Satoshi Oeda, Hirokazu Takahashi, Hisako Yoshida, et al.
Hepatology (Baltimore, Md.)
|
July 23, 2015
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers
Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
July 13, 2022
General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy
Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group
Keiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Medical Virology
|
October 12, 2022
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
Shun Kaneko, Masayuki Kurosaki, Toshie Mashiba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 12, 2026
Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan
Hironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, et al.
Plos One
|
June 28, 2013
Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
Yoshihiro Kamada, Maaya Akita, Yuri Takeda, et al.
Page
of 56
Search research articles
Search
Showing results (481-490 of 556) with videos related to
Sort By:
Page
of 56
World Journal of Gastroenterology
|
August 12, 2014
Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease
Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 8, 2021
Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study
Hirokazu Takahashi, Takashi Nakahara, Tomomi Kogiso, et al.
Journal of Gastroenterology
|
November 27, 2013
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
Takashi Nakahara, Hideyuki Hyogo, Masato Yoneda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 7, 2017
Prevalence of pruritus in patients with chronic liver disease: A multicenter study
Satoshi Oeda, Hirokazu Takahashi, Hisako Yoshida, et al.
Hepatology (Baltimore, Md.)
|
July 23, 2015
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers
Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
July 13, 2022
General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy
Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 3, 2025
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group
Keiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Medical Virology
|
October 12, 2022
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
Shun Kaneko, Masayuki Kurosaki, Toshie Mashiba, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 12, 2026
Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan
Hironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, et al.
Plos One
|
June 28, 2013
Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
Yoshihiro Kamada, Maaya Akita, Yuri Takeda, et al.
Page
of 56